Antimicrobial sanitizing lotion with skin protection properties
OwnerKevin Stackinventor
Life of this patent
Estimating the term…
Abstract
The present invention is directed toward an antimicrobial hand sanitizing lotion in the form of a medicated polymer/emulsion based product and the method by which it is produced. The product is intended to be used as a topical antimicrobial and skin protective lotion and contains 2,4,4′-trichloro-2′-hydroxydiphenyl ether as the antimicrobial agent of choice in a base which forms a hydrophobic protective barrier, having persistent antimicrobial properties, upon application to the skin.
Claims3
A method for forming a topical antimicrobial skin sanitizing and conditioning composition comprising:
- 1) forming a surfactant phase mixture, based upon a percentage by weight of the total composition, by first combining 83.5 wt. % deionized water, 0.16 wt. % EDTA Sodium Salt and 0.35 wt. % of an acrylic polymer within a vessel containing mixing means and recirculating means;
- 2) operating said mixing means in the reverse mode while operating the recirculation means at 100-150 gpm at a pressure of 60-110 psi, whereby the acrylic polymer is completely solubilized in said surfactant phase mixture;
- 3)homogenizing said surfactant phase mixture for 30-40 minutes under conditions sufficiently rigorous to yield a grain free, homogeneously blended mixture;
- 4) further adding, in the order and amounts stated, 3.0 wt. % Octyl Phenyoxypolyethoxy non-ionic surfactant, 1.0 wt. % Propylene Glycol (USP), 2.0 wt. % Nonylphenol polyethylene glycol ether non-ionic surfactant;
- 0.1 wt. % Sodium O-Phenylphenatetetrahydrate, 0.13 wt. % 2,4,4′-trichloro-2′-hydroxydiphenyl ether, 1.0 wt. % Triethanolamine 85% N.F., 0.16 wt. % Chlorhexidine Digluconate 20%, and 0.1 wt. % Alpha Tocopherol to said surfactant phase mixture;
- 5)further mixing the above ingredients to form a homogeneous blend while heating to within a temperature range of 70° C.-85° C.;
- 6)maintaining the surfactant phase mixture within said temperature range while mixing and pump recirculation are continued;
- 7)in a separate vessel, forming a wax phase mixture by combining 3.0 wt. % Stearic Acid, 1.5 wt. % Cetyl Alcohol N.F., 0.75 wt. % Ethylene Glycol Monostearate, 2.0 wt. % Dimethicone, and 0.25 wt. % USP White Wax;
- 8) heating said wax phase mixture to within a temperature range of 70° C.-85° C. and maintaining the temperature of said wax phase mixture within said temperature range while mixing;
- 9) adding the wax phase mixture to said surfactant phase mixture to form a final phase mixture under conditions of homogenization, recirculation and pressure for 45-60 minutes;
- 10) lowering the temperature of said final phase mixture to less than 50° C.;
- and
- 11) adding 1.0 wt. % of a mixture of Methyl,Ethyl,Propyl and Butyl Parabenzene in a Phenoxy-Ethanol solvent and continuing homogenization for an additional 20-30 minutes with total recirculation at a rate of about 100-150 gpm at a pressure of 60-110 psi.
A method for forming a topical antimicrobial skin sanitizing and conditioning composition comprising:
- 1) forming a surfactant phase mixture, based upon a percentage by weight of the total composition, by first combining 75-85 wt. % deionized water, 0.136-0.184 wt. % EDTA Sodium Salt and 0.245-0.455 wt. % of an acrylic polymer within a vessel containing mixing means and recirculating means;
- 2) operating said mixing means in the reverse mode while operating the recirculation means at 100-150 gpm at a pressure of 60-110 psi, whereby the acrylic polymer is completely solubilized in said surfactant phase mixture;
- 3) homogenizing said surfactant phase mixture for 30-40 minutes under conditions sufficiently rigorous to yield a grain free, homogeneously blended mixture;
- 4) further adding, in the order and within the range of amounts stated, 2.55-3.45 wt. % Octyl Phenyoxypolyethoxy non-ionic surfactant, 0.85-1.15 wt. % Propylene Glycol (USP), 1.70-2.30 wt. % Nonylphenol polyethylene glycol ether non-ionic surfactant;
- 0.1-0.5 wt. % Sodium O-Phenylphenatetetrahydrate, 0.10-0.35 wt. % 2,4,4′-trichloro-2′-hydroxydiphenyl ether, 0.85-1.15 wt. % Triethanolamine 85% N.F., 0.16-0.75 wt. % Chlorhexidine Digluconate 20%, and 0.09-0.11 wt. % Alpha Tocopherol to said surfactant phase mixture;
- 5) further mixing the above ingredients to form a homogeneous blend while heating to within a temperature range of 70° C.-85° C.;
- 6) maintaining the surfactant phase mixture within said temperature range while mixing and pump recirculation are continued;
- 7) in a separate vessel, forming a wax phase mixture by combining 2.55-3.45 wt. % Stearic Acid, 1.35-1.65 wt. % Cetyl Alcohol N.F., 0.675-0.825 wt. % Ethylene Glycol Monostearate, 1.7-2.3 wt. % Dimethicone, and 0.213-0.288 wt. % USP White Wax;
- 8) heating said wax phase mixture to within a temperature range of 70° C.-850° C. and maintaining the temperature of said wax phase mixture within said temperature range while mixing;
- 9) adding the wax phase mixture to said surfactant phase mixture to form a final phase mixture under conditions of homogenization, recirculation and pressure for 45-60 minutes;
- 10) lowering the temperature of said final phase mixture to less than 50° C.;
- and
- 11) adding 1.0-3.0 wt. % of a mixture of Methyl,Ethyl,Propyl and Butyl Parabenzene in a Phenoxy ethanol solvent and continuing homogenization for an additional 20-30 minutes with total recirculation at a rate of about 100-150gpm at a pressure of 60-110 psi.
Dependencies are inferred from the claim text.